Pyxis Oncology (PYXS) Return on Assets (2021 - 2025)

Pyxis Oncology (PYXS) has 5 years of Return on Assets data on file, last reported at 0.01% in Q4 2025.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.01% in Q4 2025; TTM through Dec 2025 was 0.01%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.01%, up from 0.01% in the prior quarter.
• Over the last five years, Return on Assets for PYXS reached as high as 0.0% in Q2 2024 and fell as low as 0.01% in Q3 2025.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
• Across the five-year window, Return on Assets changed 0 bps in 2022 and fell 1 bps in 2025, its largest moves.
• Year by year, Return on Assets stood at 0.01% in 2021, then slipped by 17 bps to 0.01% in 2022, then soared by 30 bps to 0.0% in 2023, then slipped by 3 bps to 0.0% in 2024, then sank by 69 bps to 0.01% in 2025.
• Per Business Quant data, the three most recent Return on Assets figures were 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.